Cannibinor is on a lot of 'lists' however, the last thing heard was the clinical trial failure a few years ago. When stuff like that happens to a company like PARS, it's devastating. It deregistered, the officers left, there's nothing verifiable to tie PARS to the MJ sector so, it's probably best you haven't got any yet.
I know PARS was doing the same thing as GWPH, I remember GWPH used to be a foreign OTC stock, I started the iHub board for it, now it's on NASDAQ. The same crazy stuff could happen to PARS but, there's nothing to indicate that type of move.
Just a tip... click on 'Public Reply' to reply to a specific user. That way we know who you're talking too.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.